Articles by James Calloway
GE Aerospace Faces Shareholder Pushback on Human Rights Review Proposal
Two shareholder groups are urging GE Aerospace investors to vote against a proposal calling for an independent review of human rights risk assessments in defense sales. The company's board opposes the measure ahead of the May 5 annual meeting.
Grab's $600M Taiwan Expansion Faces Antitrust Review Over Uber Ties
Grab Holdings' planned $600 million acquisition of Foodpanda Taiwan is under regulatory review, with authorities examining Uber's influence as a major shareholder. The deal, expected to close in late 2026, represents Grab's first move beyond its Southeast Asian home market.
Plug Power Shares Extend Decline as CEO Sticks to 2028 Profitability Target
Plug Power shares continued their downward trajectory, closing at $2.18 on Friday, while CEO Jose Luis Crespo reiterated the company's path to profitability by 2028. The hydrogen firm reported $368.5 million in unrestricted cash at year-end 2025.
Duolingo's Strategic Shift to User Growth Pressures 2026 Outlook
Duolingo shares fell 2.8% after management projected softer 2026 bookings growth and reduced profitability margins, prioritizing user expansion over immediate revenue.
AT&T Gains on Dividend, Q1 Cash Flow in Focus Ahead of Earnings
AT&T shares advanced following its dividend declaration, but Wall Street is focused on first-quarter cash flow projections and the company's execution of its fiber and 5G strategy ahead of April earnings.
Rezolve AI Shares Surge Ahead of Key Earnings Report
Rezolve AI's stock climbed 12% in extended trading Friday, reaching $2.67, ahead of its critical full-year 2025 earnings release on Monday. The company has projected at least $40 million in revenue for 2025 and $350 million for 2026.
VinFast Shares Surge 18.5% Weekly Despite Widening Losses
VinFast Auto shares surged over 5% Friday, capping an 18.5% weekly gain, after preliminary results showed 2025 EV deliveries more than doubled. However, the company's Q4 net loss widened significantly to approximately $1.4 billion.
Vertex Shares Slide on Updated Safety Warnings for CF Drugs
Vertex Pharmaceuticals shares declined 4.6% to $433.07 following updated U.S. safety labels for its cystic fibrosis drugs citing serious neuropsychiatric events. The company maintains its 2026 revenue outlook remains heavily dependent on CF treatments.
Plug Power Slides Amid Broader Selloff Despite CEO's Profitability Reassurance
Plug Power shares fell Friday as new CEO Jose Luis Crespo reaffirmed the company's timeline to reach positive EBITDA in late 2026 and full profitability by 2028, despite reporting a substantial net loss for 2025.
EPA Grants Summer E15 Waiver to Ease Gas Prices, Impact May Be Limited
The U.S. EPA issued an emergency waiver permitting summer sales of E15 gasoline starting May 1 to address high pump prices. However, infrastructure and supply limitations may curb the policy's effectiveness.
Unity Stock Soars on Upbeat Q1 Forecast and Strategic Divestment Plan
Unity Software's stock jumped 11% to $19.01 following an improved first-quarter outlook and a strategic decision to divest slower-growth advertising and publishing units.